SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ArQule, Inc. (ARQL)
An SI Board Since April 2003
Posts SubjectMarks Bans Symbol
545 40 0 ARQL
Emcee:  tuck Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
370I must say, 501 seems a bit disappointing so far, though it clearly has activitytuck-7/25/2007
369Couldn't help it. Bought more today. $6.32.keokalani'nui-7/25/2007
368[Nonhomologous End Joining Is Essential for Cellular Resistance to the Novel Anttuck-7/21/2007
367Maybe EXELery Queen can help with another stock I am interested in.FiloF-7/18/2007
366Tom that one nearly went over my head...had to read it the second time to catch Arthur Radley-7/18/2007
365Bring in Agatha Christie's Arqule Poirot - he'll figure it out.tom pope-7/18/2007
364Company announced completion of stock offering at $7.75 and additional sell for Arthur Radley-7/18/2007
363BVF filed SCHEDULE 13G on June 25 disclosing 6.5 % ownership stake Date of eventLee39-6/26/2007
362ArQule Prices Stock Offering Thursday June 14, 7:35 am ET ArQule Prices Secondaridos-6/14/2007
361Could be because of the offering, put new stuff in an 8K for the prospectus and rkrw-6/12/2007
360Thanks. But why no PR? Not just the change in formulation but also included inkenhott-6/12/2007
359<<I bet they are reformulating to boost concentration/activity.>> Itommysdad-6/10/2007
358I don't disagree with that but among the three, Chelsea gave fair warning mokeokalani'nui-6/9/2007
357Starting to see that more and more with companies not having their formulation drkrw-6/9/2007
356thestreet.com Feurestein comments on ARQLArthur Radley-6/9/2007
355I don't understand this. I have nothing in my notes that warned of this poskeokalani'nui-6/8/2007
354Added a few more shares at $7.90....stock now trading over 500,000 shares.Arthur Radley-6/8/2007
353Interesting stealth trading in ARQL today....stock was down but now trading nearArthur Radley-6/8/2007
352Parts of the latest 8-K: CLINICAL TRIALS <b>ARQ 197 Phase 2 Clinical Prokenhott-6/7/2007
351Man, you are full of good vibe! :) I was going to say something like tell me whkenhott-6/7/2007
350Heavy!!! As I stated on my blog site two weeks ago, the single catalyst for thisArthur Radley-6/6/2007
349I don't know much about the Russell. But the market is looking heavy.kenhott-6/6/2007
348>> the stock has only dropped by .05 today << Yeah, but it dropped scaram(o)uche-6/6/2007
347With the news of the 7M share placement the stock has only dropped by .05 today.Arthur Radley-6/6/2007
346ARQL to sell 7 m shares.kenhott-6/6/2007
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News